A Bayesian phase I/II design for cancer clinical trials combining an immunotherapeutic agent with a chemotherapeutic agent

Beibei Guo, Elizabeth Garrett-Mayer, Suyu Liu

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'A Bayesian phase I/II design for cancer clinical trials combining an immunotherapeutic agent with a chemotherapeutic agent'. Together they form a unique fingerprint.

Mathematics

Business & Economics